We are live on
!
Find out more
MRM
Michael R. Murphy Portfolio holdings
AUM
$255M
1-Year Est. Return
0.87%
This Fund
S&P 500
This Quarter
Est. Return
-15.54%
1 Year Est. Return
+0.87%
3 Year Est. Return
+93.92%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$291M
AUM Growth
-$27.9M
(-8.8%)
Cap. Flow
+$35M
Cap. Flow
% of AUM
12.02%
Top 10 Holdings %
Top 10 Hldgs %
67.95%
Holding
27
New
4
Increased
11
Reduced
8
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FMI
Foundation Medicine, Inc.
FMI
|
+$27.1M |
| 2 |
SQI
SCIQUEST, INC. COMMON STOCK
SQI
|
+$15.1M |
| 3 |
TUBE
TubeMogul, Inc.
TUBE
|
+$12.6M |
| 4 |
Onto Innovation
ONTO
|
+$8.12M |
| 5 |
IMPR
IMPRIVATA, INC COM
IMPR
|
+$7.34M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Supernus Pharmaceuticals
SUPN
|
+$15.7M |
| 2 |
IL
IntraLinks Holdings Inc.
IL
|
+$11.6M |
| 3 |
Mercury Systems
MRCY
|
+$8.88M |
| 4 |
YDLE
YODLEE INC COMMON STOCK
YDLE
|
+$8.82M |
| 5 |
EXA
EXA Corporation
EXA
|
+$7.73M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 59.09% |
| 2 | Healthcare | 19.84% |
| 3 | Miscellaneous | 10.98% |
| 4 | Real Estate | 5.06% |
| 5 | Consumer Discretionary | 4.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Agilysys
AGYS
$3.32B
| $25.2M | 8.65% |
2,263,632
| – | – |
|
|
BV
2
DELISTED
Bazaarvoice, Inc.
BV
| $23.4M | 8.03% |
5,181,610
+347,316
| +7% | +$1.86M |
|
|
TUBE
3
DELISTED
TubeMogul, Inc.
TUBE
| $23.1M | 7.95% |
2,199,319
+1,010,864
| +85% | +$12.6M |
|
|
HIVE
4
DELISTED
Aerohive Networks
HIVE
| $22.2M | 7.64% |
3,719,359
+947,691
| +34% | +$6.51M |
|
|
ININ
5
DELISTED
Interactive Intelligence Group, inc.
ININ
| $21.1M | 7.24% |
709,665
+134,502
| +23% | +$5.14M |
|
|
FMI
6
DELISTED
Foundation Medicine, Inc.
FMI
| $20M | 6.87% |
+1,084,393
| New | +$27.1M |
|
|
IIP
7
DELISTED
INTERNAP NETWORK SERVICES CORPORATION
IIP
| $19.6M | 6.72% |
3,193,330
+201,648
| +7% | +$1.24M |
|
|
ARPI
8
DELISTED
AMERICAN RESIDENTIAL PPTYS INC COM
ARPI
| $14.7M | 5.06% |
853,605
+31,867
| +4% | +$563K |
|
|
9
Supernus Pharmaceuticals
SUPN
$2.54B
| $14.4M | 4.96% |
1,028,304
-846,923
| -45% | -$15.7M |
|
10
Murphy USA
MUSA
$9.25B
| $14.1M | 4.83% |
256,084
-26,440
| -9% | -$1.41M |
|
|
NUVA
11
DELISTED
NuVasive, Inc.
NUVA
| $13.5M | 4.63% |
279,451
-121,543
| -30% | -$6.28M |
|
|
SQI
12
DELISTED
SCIQUEST, INC. COMMON STOCK
SQI
| $12.4M | 4.25% |
+1,238,199
| New | +$15.1M |
|
|
AMBR
13
DELISTED
Amber Road Inc
AMBR
| $10.9M | 3.74% |
2,578,583
+647,198
| +34% | +$3.47M |
|
|
IMPR
14
DELISTED
IMPRIVATA, INC COM
IMPR
| $9.17M | 3.15% |
515,814
+410,501
| +390% | +$7.34M |
|
15
TechTarget
TTGT
$281M
| $8.85M | 3.04% |
1,038,100
+749,672
| +260% | +$6.89M |
|
|
16
Onto Innovation
ONTO
$16.6B
| $8.76M | 3.01% |
721,839
+573,700
| +387% | +$8.12M |
|
17
Gilat Satellite Networks
GILT
$766M
| $6.14M | 2.11% |
1,738,312
-155,167
| -8% | -$742K |
|
|
IL
18
DELISTED
IntraLinks Holdings Inc.
IL
| $5.64M | 1.94% |
680,195
-1,090,415
| -62% | -$11.6M |
|
19
eGain
EGAN
$203M
| $5.33M | 1.83% |
1,343,391
+1,318,734
| +5,348% | +$5.39M |
|
|
AKAO
20
DELISTED
Achaogen Inc
AKAO
| $5.13M | 1.76% |
+890,813
| New | +$6.07M |
|
|
NUTR
21
DELISTED
Nutraceutical International Co
NUTR
| $4.71M | 1.62% |
199,687
-271,300
| -58% | -$6.49M |
|
|
EXA
22
DELISTED
EXA Corporation
EXA
| $2.02M | 0.69% |
195,289
-716,614
| -79% | -$7.73M |
|
|
REN
23
DELISTED
Resolute Energy Corporaton
REN
| $576K | 0.2% |
296,896
-235,667
| -44% | -$673K |
|
|
OPWR
24
DELISTED
OPOWER INC COM STK (DE)
OPWR
| $240K | 0.08% |
+26,963
| New | +$267K |
|
|
25
Mercury Systems
MRCY
$5.32B
| – | – |
-606,784
| Closed | -$8.88M |
|
Similar funds
3I
PTA
DAM
IMAS
ACMM
AAM
RDM
FNB
Michael R. Murphy's Q3 2015 Portfolio in Review
As of Q3 2015, Michael R. Murphy held 27 positions worth $291M, down 8.8% from $319M the previous quarter. Its ten largest holdings account for 68% of the portfolio.
Michael R. Murphy deployed $35M of net new capital in Q3 2015, opening 4 new positions and adding to 11 existing holdings. Its largest new stake was Foundation Medicine, Inc.: 1,084,393 shares worth $20M.
By sector, the portfolio is most concentrated in Technology at 59% of assets, up from 54% a quarter earlier, followed by Healthcare and Miscellaneous.
On the sell side, the largest reduction was Supernus Pharmaceuticals, an estimated $15.7M trimmed.
- Michael R. Murphy's largest Q3 2015 buy was Foundation Medicine, Inc.: 1,084,393 shares worth $20M.
- Michael R. Murphy added most to TubeMogul, Inc. in Q3 2015, an estimated $12.6M increase.
- Michael R. Murphy's biggest Q3 2015 reduction was Supernus Pharmaceuticals, cutting an estimated $15.7M.
- Michael R. Murphy fully exited Mercury Systems in Q3 2015, selling an estimated $8.88M.
- Michael R. Murphy's ten largest holdings make up 68% of its $291M portfolio in Q3 2015.
- Michael R. Murphy opened 4 new positions and closed 3 in Q3 2015.
- Michael R. Murphy's portfolio value fell 8.8% quarter-over-quarter to $291M.
Based on Michael R. Murphy's 13F filing for Q3 2015, filed 13 Nov 2015.